Rule 170 of the Drugs and Cosmetics Rules
On 27th August, 2024, the Supreme Court of India, while hearing the case against Patanjali Ayurved, pulled up the AYUSH Ministry for its July 1, 2024, notification asking state licensing authorities “not to initiate/take any action under” Rule 170 of the Drugs and Cosmetics Act, 1940.
What is Rule 170?
- Introduction Date: It was introduced in 2018 to govern the manufacture, storage, and sale of medicines in the country, “specifically for controlling inappropriate advertisements of Ayurvedic, Siddha and Unani medicines”.
- Rationale: The rule was introduced after a parliamentary standing committee highlighted the problem of misleading claims, and the need for the ....
Do You Want to Read More?
Subscribe Now
To get access to detailed content
Already a Member? Login here
Take Annual Subscription and get the following Advantage
The annual members of the Civil Services Chronicle can read the monthly content of the magazine as well as the Chronicle magazine archives.
Readers can study all the material since 2018 of the Civil Services Chronicle monthly issue in the form of Chronicle magazine archives.
India Watch
- 1 Lokpal's Inquiry Wing: New Push towards Anti-Corruption Efforts
- 2 Cabinet Accepts Recommendations on Simultaneous Elections
- 3 National Conference on Universal Access to Healthcare
- 4 Parliamentary Committee on Official Language
- 5 20th Maritime State Development Council
- 6 First Meeting of ANRF Governing Board
- 7 SC Emphasises Establishment of Gram Nyayalayas
- 8 Supreme Court Tightens Law on Child Pornography
- 9 7th National Security Strategy Conference, 2024
- 10 New Initiatives for Cyber Crime Prevention
